Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-564 | |
Phytochemical name or plant extracts | Dendrophthoe pentandra extract | |
PMID | 34264566 | |
Literature evidence | The combinations of paclitaxel-NPDP significantly inhibit proliferation of cells (P<0.001) and it is able to induce G2/M cell cycle arrest (P<0.001). | |
IUPAC name | NA | |
Phytochemicals’ class or type of plant extracts | Extract nanoparticle | |
Source of phytochemicals or plant Extracts | Dendrophthoe pentandra | |
Geographical availability | Assam, Bangladesh, Borneo, Cambodia, China South-Central, China Southeast, Jawa, Laos, Lesser Sunda Is., Malaya, Myanmar, Nepal, Philippines, Sumatera, Thailand, Vietnam | |
Plant parts | Leaves | |
Other cancers | Breast cancer | |
Target gene or protein | TUBB3, MAP4 | |
Gene or Protein evidence | These results indicate that the combination of NPDP nanoparticles could reduce the expressions of TUBB3 and MAP4. | |
Target pathways | NA | |
IC50 | NA | |
Potency | The combinations of paclitaxel-NPDP significantly inhibit proliferation of cells (P<0.001) and it is able to induce G2/M cell cycle arrest (P<0.001). The combination of paclitaxel-NPDP significantly decreases the expressions of TUBB3 (P<0.001) and MAP4 (P<0.001) in MCF-7 cells. | |
Cell line/ mice model | MCF-7 | |
Additional information | MCF-7 cells are cultured and divided into six groups: group 1 was a negative control (without paclitaxel or NPDP), group 2 was treated with paclitaxel alone, groups 3-5 were treated with NPDP (2, 4, and 8 mg/mL, respectively) and group 6 was treated only by 8 mg/mL of chitosan-NPDP nanoparticles. | |
PubChem ID | NA | |
Additional PMIDs | NA | |
Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:548340-1 | |
Safety | NA |